EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Notch signaling genes and CD8 + T‐cell dynamics: Their contribution to immune‐checkpoint inhibitor therapy in oral squamous cell carcinoma: A retrospective study

Kazuhiro Ogi iD, Takahiro Iwamoto, Takashi Sasaya, Koyo Nishiyama, Takaaki Tokura, Takanori Sasaki, Hironari Dehari, Yohei Arihara, Kazuyuki Murase, Masato Saito, Masanori Someya, Kohichi Takada und 1 weitere

Cancer Medicine · 2024

DOI: 10.1002/cam4.6985 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Kazuhiro Ogi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Surgery, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Mouth Neoplasms, Head and Neck Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Science for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Aberrant Notch signaling pathway has been related with the tumorigenesis in head and neck region, involving oral cavity. Here, we report the correlation between mutations in the Notch signaling pathway and CD8 + T‐cell infiltration via PD‐L1, which lead to enhanced antitumor immunity and may target for immune‐checkpoint inhibitors (ICIs) therapy.

Methods

This retrospective study analyzed the results of immunohistochemical staining for PD‐L1 and CD8 + T‐cell infiltration in 10 patients and whole‐exome sequencing (WES) was conducted on five of these patients to identify frequently mutated genes.

Results

Four of 10 patients were positive for PD‐L1 and CD8 + T. By analyzing WES in three of these four patients, we notably identified the mutations of NOTCH1, FBXW7, and noncoding RNA intronic mutation in NOTCH2NLR in two of these three patients. This study may enable better selection of ICI therapy with CD8 + T‐cell infiltration via PD‐L1 expression for oral squamous cell carcinoma patients with mutations in Notch signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellMouth NeoplasmsHead and Neck NeoplasmsHumansSquamous Cell Carcinoma of Head and NeckImmune Checkpoint InhibitorsRetrospective StudiesB7-H1 AntigenCD8-Positive T-Lymphocytes

Stichwörter der Autor:innen

CD8+ T cellimmunotherapynotch signaling geneoral squamous cell carcinoma

Substanzen

Immune Checkpoint InhibitorsB7-H1 Antigen

Autor:innen und Institutionen

  • Department of Oral Surgery, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.
  • Department of Medical Oncology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.
  • Department of Radiology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.

ORCID-Profile: Kazuhiro Ogi

Förderung

  • Japan Science for the Promotion of Science

Zitieren

APA

Ogi, K., Iwamoto, T., Sasaya, T., Nishiyama, K., Tokura, T., Sasaki, T., Dehari, H., Arihara, Y., Murase, K., Saito, M., Someya, M., Takada, K., & Miyazaki, A. (2024). Notch signaling genes and CD8 + T‐cell dynamics: Their contribution to immune‐checkpoint inhibitor therapy in oral squamous cell carcinoma: A retrospective study. Cancer Medicine. https://doi.org/10.1002/cam4.6985

Vancouver

Ogi K, Iwamoto T, Sasaya T, Nishiyama K, Tokura T, Sasaki T, et al. Notch signaling genes and CD8 + T‐cell dynamics: Their contribution to immune‐checkpoint inhibitor therapy in oral squamous cell carcinoma: A retrospective study. Cancer Medicine. 2024. doi:10.1002/cam4.6985

BibTeX
@article{Ogi2024,
  author = {Ogi, Kazuhiro and Iwamoto, Takahiro and Sasaya, Takashi and Nishiyama, Koyo and Tokura, Takaaki and Sasaki, Takanori and Dehari, Hironari and Arihara, Yohei and Murase, Kazuyuki and Saito, Masato and Someya, Masanori and Takada, Kohichi and Miyazaki, Akihiro},
  title = {Notch signaling genes and CD8 + T‐cell dynamics: Their contribution to immune‐checkpoint inhibitor therapy in oral squamous cell carcinoma: A retrospective study},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.6985}
}
Kostenlos starten →